CMPX earnings: a positive outcome, +5.7%

+5.7%Compass Therapeutics, Inc. (CMPX) →

On March 21, 2024, Compass Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.7% in the window around the event. It had already run +21.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$2.12

1d before

$2.24

Event day

$2.13

1d after

$1.98

5d after

Pre-catalyst setup

+21.6%

30-day run-up

10175%

30-day volatility

1.7×

volume spike

CMPX catalyst calendar More earningss Prediction track record Full catalyst calendar